
Markus Gershater on Why Experimental Design in Biotech is Broken and How to Fix It
From Data in Biotech by CorrDyn
April 15, 2026 · 41 min · Season 1 · Episode 2
About this episode
Markus Gershater discusses the flaws in current experimental design in biotech and potential solutions.
This week, we're delighted to be joined by Markus Gershater, Chief Scientific Officer and CoFounder of Synthace - a digital experiment platform built for high-performance life science R&D teams to help them run more powerful experiments and accelerate scientific progress. Host Ross Katz speaks with Markus on what’s broken about: What’s broken about how laboratories across the globe run biological experiments at scale The opportunity that exists for researchers in striving to achieve experimental design automation processes Why, as an industry, we must move towards implementing infrastructure that enables multifactorial experiments versus one-factor experiments And the role of AI in making sense of complex systems. --- If you’re a biotech company struggling to transform your business with data, CorrDyn can help. Whether you need to supplement existing technology teams with specialist expertise or launch a data program that lays the groundwork for future internal hires, you can partner with Corrdyn to unlock the potential of your business data - today. Visit connect.corrdyn.com/biotech to learn more. --- Data in Biotech is a fortnightly podcast exploring how companies leverage…
People in this episode
Host: Ross Katz
Guest: Markus Gershater
Topics covered
- experimental design
- biotech
- automation
- AI in research
- scientific progress
Keywords
- biological experiments
- experimental design automation
- multifactorial experiments
- AI
- life sciences
Sponsors
CorrDyn
Mentioned in this episode
Organizations: Synthace
More episodes of Data in Biotech
- From Tissue to Mechanism to Decision: Building AI for Computational Oncology · June 2, 2026 · 47 min
- Cavities in the Data: Building FDA-Cleared AI for Dental Imaging with Overjet · May 13, 2026 · 59 min
- Data as a Moat: Why Biotech's Most Valuable Asset is Buried in a Hard Drive · April 30, 2026 · 43 min
- Data Science and Diagnostic Models - the What, Why and How with Michelle Wiest · April 15, 2026 · 44 min
- The Patient is Not a Document: Foundation Models for Biomedical AI with Standard BioModel · April 15, 2026 · 50 min
- Physics, Free Energy, & Drug Discovery: Inside Schrödinger's Computational Platform · April 1, 2026 · 58 min
Explore listener stats, chart rankings, contacts and more on the Data in Biotech podcast page.